Sunny Pharmtech Inc. (TPEX:6676)
9.34
-0.33 (-3.41%)
Oct 30, 2026, 1:55 PM CST
Sunny Pharmtech Revenue
Sunny Pharmtech had revenue of 86.08M TWD in the half year ending June 30, 2026, a decrease of -63.14%. This brings the company's total for the last twelve months to 233.36M, down -19.58% year-over-year. In the year 2025, Sunny Pharmtech had annual revenue of 253.01M, down -39.47%. That makes Sunny Pharmtech the 38,721st largest company in the world by revenue and 2,015th in Taiwan.
Revenue (ttm)
233.36M
Revenue Growth
-19.58%
P/S Ratio
5.59
Revenue / Employee
1.46M
Employees
160
Market Cap
1.30B
Revenue by Geography
- United States 146.57M 57.9%
- Taiwan 103.83M 41.0%
- Others 2.61M 1.0%
Fiscal year ended Dec 31, 2025 See the full Sunny Pharmtech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.01M | -165.00M | -39.47% |
| Dec 31, 2024 | 418.01M | -10.82M | -2.52% |
| Dec 31, 2023 | 428.83M | 69.24M | 19.26% |
| Dec 31, 2022 | 359.59M | 118.59M | 49.21% |
| Dec 31, 2021 | 241.00M | -178.94M | -42.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.01B |
| GenMont Biotech Incorporation | 382.11M |
| Abnova (Taiwan) | 345.45M |
| NeoCore Technology | 277.54M |
| Enimmune | 53.45M |
| TaiRx | 29.44M |
| Anti-Microbial Savior BioteQ | 1.26M |